Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Hardline who wrote (2617)	10/9/1998 11:39:00 AM
From: Alys Hall	Respond to of 3702

Yes..I like the buy side a lot better here than at 1.25. For those of us who did not buy and then sell again at $1.50+, here is another opportunity. However, how about these questions: 1. Does the Company still own Lym 1? 2. How are the TNT-- Glioma trials progressing? 3. What is the likelihood of this Company surviving? This stock has been destroyed during the past year, it didn't need the overall market to kill it. However, I thought that we were progressing towards some promising results coming from Phase II/III. Are my assumptions wrong? Also..why is our favorite bull missing in action. No one seems to have heard from Davis in a while.